MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered ...
Graphano Energy Ltd. (TSXV: GEL) (FSE: 97G0) ("Graphano" or the "Company") announces that it is undertaking a non-brokered ...
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today ...
StephenTwomey.com has published a new resource titled “Accredited Investors’ 2025 Guide: Hedge Funds, Alternative Investments & Private Placements”, offering a forward-looking analysis for investors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback